UK markets close in 5 hours 23 minutes
  • FTSE 100

    7,008.18
    +44.85 (+0.64%)
     
  • FTSE 250

    22,233.96
    +164.65 (+0.75%)
     
  • AIM

    1,227.98
    +3.14 (+0.26%)
     
  • GBP/EUR

    1.1608
    -0.0018 (-0.16%)
     
  • GBP/USD

    1.4057
    +0.0005 (+0.04%)
     
  • BTC-GBP

    35,818.10
    +233.43 (+0.66%)
     
  • CMC Crypto 200

    1,394.13
    +6.22 (+0.45%)
     
  • S&P 500

    4,112.50
    +49.46 (+1.22%)
     
  • DOW

    34,021.45
    +433.79 (+1.29%)
     
  • CRUDE OIL

    64.48
    +0.66 (+1.03%)
     
  • GOLD FUTURES

    1,833.90
    +9.90 (+0.54%)
     
  • NIKKEI 225

    28,084.47
    +636.46 (+2.32%)
     
  • HANG SENG

    28,027.57
    +308.90 (+1.11%)
     
  • DAX

    15,292.78
    +93.10 (+0.61%)
     
  • CAC 40

    6,334.83
    +46.50 (+0.74%)
     

Insights on the Intracranial Aneurysm Global Market to 2025 - Competitive Analysis and the Impact of COVID-19

Research and Markets
·6-min read

Dublin, April 21, 2021 (GLOBE NEWSWIRE) -- The "Global Intracranial Aneurysm Market (2020-2025) by Type, Condition, Treatment Type, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Intracranial Aneurysm Market is estimated to be USD 1.1 Bn in 2020 and is expected to reach USD 1.78 Bn by 2025, growing at a CAGR of 9.2%.

Market Dynamics

Key factors such as the growing prevalence of strokes and haemorrhages followed by the increasing incidences of hypertension and artery wall disorders amongst the individuals are the common drivers for the growth of the Intracranial Aneurysm Market. Similarly, the preference for minimally invasive procedures with the availability of medicines and devices is boosting the growth of the market further. Moreover, the increasing healthcare funding by government bodies, the adoption of advanced technologies and novel devices, and the growing research and development activities are creating potential opportunities for the market.
However, factors such as high treatment costs and unrecognized symptoms of the brain aneurysm are likely to restrain the market growth.

Market Segmentation

The Global Intracranial Aneurysm Market is segmented further based on Type, Condition, Treatment Type, End-User, and Geography.

By Type, the market is classified as Surgical Clipping, Endovascular Coiling, Flow Diverters, and others. Amongst all, the endovascular coiling segment holds the highest market share.

By Condition, the market is classified as an unruptured aneurysm and Ruptured aneurysm. Amongst all, the ruptured aneurysm segment holds the highest market share.

By Treatment Type, the market is classified as Medication and Surgery. Amongst all, the surgery segment holds the highest market share.

By End-user, the market is classified as Hospital & Clinics, Diagnostic Centers, and others. Amongst all, the hospital segment holds the highest market share.

By Geography, North America is projected to lead the market.

Recent Developments
1. Stryker Corp has launched its Surpass Evolve flow diverter (a 64-wire cobalt-chromium flow diverter) in the US for redirecting blood flow and handling aneurysm healing. - 24th August 2020
2. Raumedic introduces an intracranial pressure monitoring device - Raumed Home for patients seeking ICP monitoring at home. - 13th November 2019

Company Profiles

Some of the companies covered in the report are Raumedic AG, DePuy Synthes, Integra Life Sciences Corporation, Orsan Medical Technologies, B Braun, Medtronic Plc., and Stryker Corp, etc.

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Intracranial Aneurysm Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.

  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.

  • The report includes in-depth market analysis using Porter's 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.

  • The report also contains the competitive analysis using the Competitive Quadrant, the analyst's proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry

  • Important market dynamics and trends

  • Market segmentation

  • Historical, current, and projected size of the market based on value and volume

  • Market shares and strategies of key players

  • Recommendations to companies for strengthening their foothold in the market

Key Topics Covered:

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders

2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.3 Market Size Estimation
2.4 Assumptions of the Study
2.5 Limitations of the Study

3 Executive Summary

4 Market Overview
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Growing prevalence of strokes and hemorrhages
4.2.1.2 Increasing incidence of hypertension and arteriosclerosis amongst individuals
4.2.1.3 Increasing demand for minimally invasive procedures
4.2.2 Restraints
4.2.2.1 High treatment cost
4.2.2.2 Unrecognized symptoms of the brain aneurysm
4.2.2.1 Higher risk of aneurysm recurrence
4.2.3 Opportunities
4.2.3.1 Adoption of advanced technologies and novel devices
4.2.3.2 Increasing healthcare funding by government bodies
4.2.3.3 Rise in research and development activities
4.2.4 Challenges
4.2.4.1 Commercialization of the products in the developing economies
4.3 Trends

5 Market Analysis
5.1 Porter's Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis

6 Global Intracranial Aneurysm Market, By Type
6.1 Introduction
6.2 Surgical Clipping
6.3 Endovascular Coiling
6.4 Flow Diverters
6.5 Others

7 Global Intracranial Aneurysm Market, By Condition
7.1 Introduction
7.2 Unruptured Aneurysm
7.3 Ruptured Aneurysm

8 Global Intracranial Aneurysm Market, By Treatment Type
8.1 Introduction
8.2 Medication
8.3 Surgery

9 Global Intracranial Aneurysm Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Specialty Clinics
9.4 Others

10 Global Intracranial Aneurysm Market, by Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 South America
10.3.1 Brazil
10.3.2 Argentina
10.4 Europe
10.4.1 UK
10.4.2 France
10.4.3 Germany
10.4.4 Italy
10.4.5 Spain
10.4.6 Rest of Europe
10.5 Asia-Pacific
10.5.1 China
10.5.2 Japan
10.5.3 India
10.5.4 Indonesia
10.5.5 Malaysia
10.5.6 South Korea
10.5.7 Australia
10.5.8 Russia
10.5.9 Rest of APAC
10.6 Rest of the World
10.6.1 Qatar
10.6.2 Saudi Arabia
10.6.3 South Africa
10.6.4 United Arab Emirates
10.6.5 Latin America

11 Competitive Landscape
11.1 Competitive Quadrant
11.2 Market Share Analysis
11.3 Competitive Scenario
11.3.1 Mergers & Acquisitions
11.3.2 Agreement, Collaborations, & Partnerships
11.3.3 New Product Launches & Enhancements
11.3.4 Investments & Funding

12 Company Profiles
12.1 Medtronic
12.2 Sophysa
12.3 Microport Scientific Corporation
12.4 B. Braun
12.5 Stryker Corp.
12.6 Infrascan
12.7 Johnson and Johnson Services
12.8 Microvention Inc. (Terumo Corporation)
12.9 Spiegelberg (SHS Medizintechnik Holding GmbH)
12.10 Codman Neuro (Integra LifeSciences)
12.11 Terumo Corporation
12.12 Mizuho Medical Co, Ltd
12.13 Penumbra, Inc
12.14 KANEKA CORPORATION
12.15 Adeor medical AG
12.16 Evasc Medical Systems Corp
12.17 Orsan Medical Technologies
12.18 Raumedic AG
12.19 DePuy Synthes
12.20 Vittamed

13 Appendix
13.1 Questionnaire

For more information about this report visit https://www.researchandmarkets.com/r/l0bs3g

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900